Indium (111in) Dtpa Curium Netherlands Bv

Indium-111 pentetate, the active ingredient in Indium (111in) Dtpa Curium Netherlands Bv, is a diagnostic radiopharmaceutical presented as a solution for intrathecal use. It enables imaging of cerebrospinal fluid pathways and detection of CSF leaks in patients undergoing neuro‑diagnostic evaluation.

GNH USA supplies Indium (111in) Dtpa Curium Netherlands Bv as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

Indium (111in) Dtpa is used in diagnostic imaging of the cerebrospinal fluid system and related conditions. - Cerebrospinal fluid pathway imaging: provides high‑resolution visualization of CSF flow dynamics. - CSF leak detection: localises sites of spinal or cranial cerebrospinal fluid leakage. - Ventricular shunt assessment: evaluates patency and function of implanted CSF shunt devices.

Adverse reactions may occur following intrathecal administration of Indium‑111 pentetate.

Common Side Effects: - Headache: mild to moderate discomfort after the procedure. - Nausea: transient feeling of queasiness. - Transient back pain: localized at the injection site. - Mild fever: low‑grade temperature elevation. - Localized irritation: mild redness or bruising at puncture site.

Serious or Rare Side Effects: - Allergic reaction: rash, urticaria, or anaphylaxis. - Neurotoxicity: rare neurological symptoms such as seizures. - Severe infection: meningitis or spinal infection. - Radiation‑induced tissue injury: uncommon but possible with high cumulative doses. - Hemorrhage: spinal or epidural bleeding at injection site.

Prior to using Indium (111in) Dtpa, clinicians should consider several safety measures. - Pregnancy: avoid unless essential, as fetal effects are unknown. - Breastfeeding: discontinue nursing or assess risk‑benefit, due to possible radiation exposure. - Renal impairment: monitor renal function, as clearance may be altered. - Allergy history: verify no known hypersensitivity to DTPA or indium compounds. - Radiation exposure: limit repeat studies and adhere to ALARA principles. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Indium (111in) Dtpa may interact with other agents that affect imaging or CSF dynamics.

Major Interactions (Avoid): - Concurrent radiopharmaceuticals: overlapping gamma emissions can compromise image quality. - High‑dose iodinated contrast: may interfere with radionuclide detection.

Moderate Interactions (Monitor Closely): - Medications altering CSF flow (e.g., acetazolamide): may affect tracer distribution. - Anticoagulants: increase risk of spinal puncture bleeding. - Intrathecal antibiotics or steroids: could modify tracer kinetics. - Renal‑clearing drugs: monitor for altered systemic clearance.